In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Council of Cardio-Oncology Advocacy Initiatives

EU's Beating Cancer Plan

The Council, in collaboration with the ESC Advocacy Committee, contributes to the EU's Beating Cancer Plan through the following initiatives:

  • Collaboration with the European Cancer Patients Coalition.
    • Development of a White paper entitled: The impact of cancer-related comorbidities on patient treatment, treatment efficacy, survivorship, and quality of life -> pending publication.
    • Joint statement prepared calling for greater focus on cancer comorbidities.
    • Further joint initiatives are planned during the European Week Against Cancer
  • Collaboration with the European Cancer Organisation (ECO)
    • Joint letter sent to J Ryan, European Commission Health & Consumers Directorate-General, underlining cardio-oncology issues and current needs.

European Week Against Cancer

Riccardo Asteggiano, Past Chairperson of the Council of Cardio-Oncology will take part in an upcoming webinar organised during the European Week against Cancer.

May 28, 2021 16:30 CEST: Cancer-Associated Thrombosis (CAT)/ Venous Thromboembolism (VTE) and Cardiovascular Complications and how they affect cancer patients’ survival and quality of life.


Other Advocacy Initiatives

The Council is working to build collaborative initiatives with other related external societies and several Council Nucleus members are currently contributing to the development of guidelines: 

  • from the European Hematology Association on the “Cardiovascular toxicity in older adults with hematologic malignancies”
  • from the ‘ERS/ESTS Clinical Practice Guideline Task Force on Fitness for Tumour-specific Treatments of Lung Cancer’